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Abstract
Background: To investigate the rates of pneumococcal and influenza vaccinations and their determinants in
children with chronic medical conditions.
Patients and Methods: Children with HIV infection, cystic fibrosis, liver transplantation and diabetes mellitus were
enrolled. Physicians of regional Reference Centres for each condition, primary care paediatricians and caregivers of
children provided information through specific questionnaires. For diabetes, 3 Reference Centres were included.
Results: Less than 25% of children in each group received pneumococcal vaccination. Vaccination rates against
influenza were 73% in patients with HIV-infection, 90% in patients with cystic fibrosis, 76% in patients with liver
transplantation, and ranged from 21% to 61% in patients with diabetes mellitus. Reference Centres rather than
primary care paediatricians had a major role in promoting vaccinations. Lack of information was the main reason
for missing vaccination. Awareness of the severity of pneumococcus infection by key informants of at-risk children
was associated with higher vaccination rate.
Conclusions: Vaccination rates in children with chronic conditions were poor for pneumococcus and slightly
better for influenza. Barriers to vaccination include lack of awareness, health care and organization problems.
Background
Among vaccine preventable diseases, two are of out-
standing importance and provide an interesting area of
evaluation: pneumococcus and influenza infections. The
first is a relatively common and potentially severe infec-
tion for which vaccines are widely available, effective
and relatively widespread. Influenza has peculiar features
related to variable degree and the need of annual
vaccination.
Subjects with chronic medical conditions are at
increased risk for severe complications related to vac-
cine-preventable infections and should be extensively
immunized [1,2]. Influenza and invasive Streptococcus
pneumoniae infections are associated with increased
morbidity, hospitalisation and mortality in children with
chronic medical conditions compared to healthy chil-
dren [3-7].
Criteria for influenza immunization in USA by Advi-
sory Committee for Immunization Practice (ACIP) now
include all children aged 6 months to 18 years [8]. In
Italy, influenza vaccination is not routinely offered to
healthy children, whereas it is recommended and offered
without costs to children with chronic conditions. The
same is true for pneumococcal vaccination [9].
Despite long-standing recommendations to provide
pneumococcal and annual influenza vaccinations to chil-
dren with chronic medical conditions, immunization
rates in these vulnerable populations are poor [10,11].
A recent cluster survey performed in Italy showed less
than 10% coverage for influenza vaccination and a vari-
able rate for pneumococcus vaccination (49% in at-risk
children aged less than 24 months and less than 15% in
adolescents) [12].
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nations, including problems in identifying at risk chil-
dren and limited awareness of specific recommendations
[13,14]. Vaccination of at-risk children is largely a mat-
ter of organisation. In Italy, as well as in many other
western Countries, children with chronic conditions are
generally seen at specific Reference Centres, often
located in Universities or major Children’sH o s p i t a l s .
However, children with chronic diseases are seen also
by primary care paediatricians (or family paediatricians),
like all children in the Italian Health Service. Moreover,
vaccination centres provide vaccinations to both healthy
and at-risk children. Therefore, there are multiple ser-
vices through which a child with a chronic disease can
receive immunization.
The aims of the present study were to investigate the
rates and the correlates of pneumococcal and influenza
vaccinations in a large cohort of at-risk children. Four
chronic medical conditions were selected in order to
analyse different models of immunization.
Methods
Study populations
Children aged 2-18 years with the following conditions
were included: HIV infection (HIV), cystic fibrosis (CF),
type I diabetes mellitus (DM) and children who received
liver transplantation (LTx). Children <2 years and those
diagnosed as having any of the selected chronic condi-
tions since less than 1 year were excluded, in order to
evaluate the rates for influenza vaccination in two subse-
quent seasons.
Three hundred and forty-three high-risk children (174
males; median age 13 years, range 2-18) were enrolled,
including 40 patients with HIV, 39 with CF, 59 with
LTx and 205 with DM. The demographic features were
similar in all 4 groups (table 1).
Physicians involved in the management of children
with chronic diseases, including paediatricians of the
Reference Centres and primary care paediatricians, were
enrolled and received a specific questionnaire. The study
was performed in accordance with the Declaration of
Helsinki. Parents or legal guardians of children received
a specific questionnaire providing that informed consent
had been given.
Data sources
Patients with chronic medical conditions were identified
through the Regional Reference Centres for each dis-
ease. The Reference Centres for HIV infection, for CF
and for LTx (Department of Paediatrics, University Fed-
erico II) and all three Reference Centres for DM located
in Campania Region (University Federico II, Second
University and San Sebastiano Hospital of Caserta) took
part into the study.
Key instrument
A questionnaire was administered face-to-face to care-
givers of enrolled subjects with high-risk medical condi-
tions during their routine clinical evaluation at the
Reference Centre. Parental report of vaccination status
has been previously validated and has a reasonable sen-
sitivity, specificity and reliability [15,16]. The question-
naire included a demographic section with age, sex and
age at diagnosis, questions to investigate caregivers’
awareness about infection, their children’s vaccination
status for pneumococcus and influenza, and factors that
might have affected vaccination status. Children were
considered immunized against pneumococcus if they
have received heptavalent pneumococcal conjugate vac-
cine or pneumococcal polysaccharide vaccine, according
to their age. Inactivated influenza vaccine is the only
vaccine available in Italy.
In addition, a call to participate to the study was sent
by e-mail to all members of Italian Society of Paediatrics
of Campania region. One hundred and thirteen primary
care paediatricians, corresponding to approximately 15%
of the total number of primary care paediatricians of
Campania Region, accepted to participate to the study
and received a specific questionnaire on pneumococcal
and influenza diseases. Items included the specific risks
of pneumococcal and influenza infections in children
with chronic medical conditions, knowledge of current
national recommendations on vaccination and the num-
ber of patients with high-risk conditions routinely seen
at their practice. Finally, physicians of Reference Centres
were interviewed in order to investigate whether they
routinely recommend pneumococcal and influenza vac-
cinations to at-risk children.
Data analysis
Data are expressed as medians and ranges or means and
standard deviations (SD). The chi square and the t tests
for independent samples were used to compare categori-
cal and continuous variables, respectively. The Mann-
Whitney test was used to compare non parametric data.
A p value < 0.05 was considered statistically significant.
Table 1 Demographic features of 343 at-risk children
Patients HIV CF LTx DM
Number 40 39 59 205
Males 17 (43%) 18 (46%) 34 (58%) 105 (51%)
Median age in years
(range)
11 (2-18) 11 (2-18) 9.5 (2-18) 13 (2-18)
Median age at diagnosis
in years (range)
3
(1-12)
0.3
(0.1-15)
0.1
(0.1-13)
8
(2-16)
HIV, human immunodeficiency virus infection; CF, cystic fibrosis; DM, type I
diabetes mellitus; LTx, liver transplantation.
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Pneumococcal and influenza vaccination rates
Vaccination rates against pneumococcus were low and
largely below 50% in all high-risk categories, the lowest
being in subjects with DM (DM versus HIV: p = 0.0007;
DM versus CF: p = 0.02; DM versus LTx: p = 0.002)
(figure 1). Vaccinated and not vaccinated children did
not differ by sex (17/29 males versus 155/314, respec-
tively; p > 0.05) or mean duration of chronic disease
(6.3 ± 4.41 versus 7 ± 5 years; p > 0.05). However, chil-
dren who received vaccine were younger than those
who did not (mean age 8.2 ± 4.3 versus 12.5 ± 4 years,
respectively; p < 0.0001). In 2008-2009, a total of 208
(61%) of the 343 children with chronic disease condi-
tions were vaccinated for influenza and 135 (39%) were
not. A very similar pattern was observed in the same
population in 2007-2008. Similarly to findings for pneu-
mococcus, vaccination rate for influenza was signifi-
cantly lower in patients with DM compared with HIV
(p = 0.01), CF (p < 0.0001) and LTx (p = 0.0006). Influ-
enza vaccination rates in children seen in the 3 Refer-
ence Centres for DM were broad ranging from 21% to
61% (figure 1). Vaccinated children were younger than
not vaccinated (mean age 11 ± 4.2 versus 12 ± 4.2 years,
respectively; p = 0.03), but the mean duration of the
chronic conditions was significantly higher in vaccinated
subjects (7.8 ± 4.9 years) than in non vaccinated subjects
(6.5 ± 5 years; p = 0.001). This apparently surprising
result is explained by the lower age at diagnosis of chil-
dren with HIV, CF and LTx compared to DM.
Role of physicians working in different settings in
recommending vaccinations
To investigate the role in promoting immunization by
the physicians working in specific Reference Centres,
key responders were asked to report who recommended
vaccinations. As shown in figure 2A, physicians of
the Reference Centres for HIV and LTx actively
Figure 1 Pneumococcal and influenza vaccination rates in 343 high-risk children. Inset: percentage of patients with DM vaccinated for
pneumococcus and influenza seen at each of the three Reference Centres (*p < 0.05). The lowest rate of pneumococcal and influenza
vaccinations were obtained in patients with DM (p < 0.05 in all cases).
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while this was not so in the 3 centres for DM. For CF
patients, physicians of the Reference Centres and pri-
mary care paediatricians were both in charge of recom-
mending pneumococcal vaccination. Again, the
Reference Centre had a major role in recommending
influenza vaccination to children with HIV, CF and LTx,
whereas primary care paediatricians had a main role in
case of children with DM (figure 2B).
Reasons for missing vaccinations
T h e r ew a saw i d es p e c t r u mo fr e a s o n sw h yp a t i e n t s
were not vaccinated for pneumococcus and influenza,
ranging from lack of information to parental “ideologi-
cal” attitudes and concern (fig u r e3 ) .L a c ko fi n f o r m a -
tion prevailed in all groups, particularly as regards
pneumococcal vaccination.
Key informants were specifically asked whether they
would consider pneumococcus and influenza infections
as potentially serious diseases in their children. As a
control question, we also asked whether they would
consider these infections a severe problem in healthy
children. Overall, a small number of caregivers (79/343,
23%) were aware of pneumococcus infection and this
was perceived as a potentially severe infection by only
15% of them. The same percentage (53/343, 15%) of
caregivers considered influenza as a serious infection,
but an higher proportion (243/343, 71%) considered it a
severe disease in presence of underlying chronic medical
conditions. A greater proportion of caregivers of CF
(36/39, 92%) and LTx patients (50/59, 85%) were con-
cerned about influenza infection than caregivers of HIV
(25/40, 62%; p = 0.002 and p = 0.01, respectively) and
DM children (134/205, 65%; p = 0.0005 and p = 0.003,
respectively).
Awareness of the severity of pneumococcus and influ-
enza infections, as reported by caregivers, was then cor-
related with vaccination rates. Significantly more
Figure 2 Correlates of pneumococcal and influenza vaccinations in 343 high-risk children. A. Reasons for receiving pneumococcal
vaccination. Role of the Reference Centre in recommending vaccination in HIV vs CF and DM: p < 0.05. Role of the Reference Centre in
recommending vaccination in LTx vs CF and DM: p < 0.05. B. Reasons for receiving influenza vaccination. ** DM versus HIV, CF and LTx: p <
0.0001. In both histograms, “others” includes vaccination because of previous serious influenza illness, recommendation by relatives or friends,
information garnered from the mass media or not specified reason.
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cus infection could be severe, were vaccinated than
children of caregivers who did not considered pneumo-
coccus infection as severe (12% versus 32%; p < 0.0001).
No relationship between infection awareness and vacci-
nation rate was found for influenza.
Health care providers’ behaviours in recommending
vaccinations
Physicians working in 5 of 6t h eR e f e r e n c eC e n t r e s
reported that they actively recommended immunization
against pneumococcal and influenza to high-risk chil-
dren as part of their routine approach to children with
chronic conditions. Physicians working within the same
Reference Centre had a similar vaccination policy. In
one of the 3 Reference Centres for DM, paediatricians
advised influenza vaccination only to patients with poor
metabolic control, whereas vaccination was considered
unnecessary and not recommended in other children
with DM. Interestingly, only 20 (25%) of the 80 children
with DM followed at that Centre had been immunised,
thus supporting the role of Reference Centre in promot-
ing or not immunization. A total of 113 primary care
paediatricians were interviewed. The majority of them
were recommended pneumococcal (102/113, 90%) and
influenza (109/113, 96%) vaccinations for children with
chronic medical conditions.
Discussion
Vaccination against influenza of healthy children aged 6
months-18 years is recommended in the USA [8] but
not in Italy [9]. However, vaccination of children with
chronic medical conditions against a wide spectrum of
infectious diseases has been included in the Essential
Levels of Care and is provided free of charge [9].
Although it is well known that pneumococcal infec-
tion can be more severe than influenza and that pneu-
mococcal vaccine is protective for a long time, the
Figure 3 Reasons for not having pneumococcal or influenza vaccinations in 343 high-risk children. “Other source of information” includes
child barriers ("child was sick”), parents barriers ("no time”, “forgot”), system barriers ("no vaccine available”), vaccination considered unnecessary
by physician or not specified reason.
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studied groups and far lower than influenza. Data from
the United States showed that coverage rate for pneu-
mococcal polysaccharide vaccine was only 37% among
persons 18-64 year of age at increased risk for pneumo-
coccal diseases [17]. As for paediatric age, recent data
reported an estimated coverage rate for pneumococcal
conjugate vaccines of 31, 38 and 49% among children
born in 2000, 2001 and 2002, respectively [18]. Approxi-
mately 60% of children with the selected chronic condi-
tions were vaccinated against influenza. This
immunization rate was stable over two subsequent sea-
sons and was higher than that reported in previous stu-
dies [19-21].
A suboptimal vaccination rate in at-risk children may
be in part related to a lack of information, fear of side
effects of vaccination in children who are already ill, to
organisational problems, difficulties to identify at-risk
subjects and low priority by public health authorities. In
our study, immunization rates were closely related to
the underlying condition, with the lowest rate for both
vaccinations occurring in patients with DM. This may
be due to the lack of awareness of the risks related with
pneumococcus and influenza infections by physicians in
charge of children with DM.
Furthermore, for pneumococcal vaccination, “once in
the life” administration instead of annual administration
(as required by influenza vaccine) could reduce the
opportunities that physicians have to check vaccination
status. In the recent years, the Italian vaccination policy
has actively promoted pneumococcal vaccination in all
children aged less that 24 months [9]. This policy may
explain the younger age of children vaccinated for pneu-
mococcus, compared to non vaccinated, found in the
present study. Another potential reason of the low cov-
erage rate could be the lack of awareness of the severity
of pneumococcal and influenza infections in at-risk chil-
dren, as reported by caregivers of patients with HIV
and DM.
Immunization includes three different actions: to
recommend vaccination, to administer vaccine, to check
vaccination status. It was previously found that one of
the most important factors positively associated with
vaccination was recommendation by a health care provi-
der [22-24]. However, it has been reported that health
care workers’ knowledge about recommendations on
vaccinations is limited [11,25], and, in a previous study
on the determinants of influenza vaccination, the major-
ity of parents of infants stated they received information
through mass media rather than from physicians [23].
The main information that emerges from this study is
that at-risk children depend from three categories of
physicians: disease specialists, primary care physicians
and vaccination service physicians. These categories are
equally encharged with vaccination, with no clear dis-
tinction between them. This policy, characterized by a
redundancy of physicians’ roles, leads to an ineffective
recommendation and check of vaccination status.
Conclusions
Three major findings emerge from this study. Firstly,
although both pneumococcal and influenza vaccines in
Italy are provided free of charge, the immunization rate
for pneumococcal infection is very low, whereas the
immunization rate for influenza is relatively high, with a
pattern consistent over time. Secondly, for most chronic
conditions, vaccination is performed upon the advice of
a Reference Centre. Third, the main reason of unvacci-
nation was the lack of knowledge by parents of the ben-
efits of pneumococcal and influenza vaccinations in
children with chronic underlying diseases.
In conclusion, immunization should be considered
part of the global care of children with chronic medical
conditions. Considering that the lack of recommenda-
tion led to missed vaccination, providers need to be
aware that a particular condition is an indications for
influenza and/or pneumococcal vaccinations and should
actively recommend and control vaccination. For dis-
eases principally managed by Reference Centres (such as
HIV, CF and LTx), physicians of the Reference Centres
should mainly be in charge of vaccination policy. For
diseases with a has a less defined management, this role
should be played by primary care paediatricians.
To achieve optimal immunization rates in at-risk
groups a complex array of responsibilities and functions
is required. A special effort is required to implement
pneumococcal immunization among Italian high-risk
children.
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